Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) increased more than 26% in pre-market trading to $4.
In a research report issued today, MLV analyst George Zavoico reiterated a Buy rating on Threshold Pharmaceuticals (NASDAQ:THLD) with a $14.50 price target, …
In a research report released Monday, H.C.
In a research note released today, Cantor Fitzgerald analyst Daniel Brims reaffirmed a Buy rating on Threshold Pharmaceuticals (NASDAQ:THLD) with a $14 price …
In a research note released yesterday, H.C.
In a research report issued today, analyst Andrew Fein of H.C.
In a research report issued today, H.C.